Nuveen’s Zevra Therapeutics ZVRA Stock Holding History

Nuveen’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.79M	Buy	192,588 +49,456	+35%	+$446K	﹤0.01%	2317
2025 Q4	$1.28M	Sell	143,132 -9,900	-6%	-$93.6K	﹤0.01%	2490
2025 Q3	$1.46M	Buy	153,032 +9,900	+7%	+$99.3K	﹤0.01%	2437
2025 Q2	$1.26M	Buy	143,132 +28,198	+25%	+$229K	﹤0.01%	2505
2025 Q1	$6.65M	Sell	114,934 -38,143	-25%	-$303K	﹤0.01%	1775
2024 Q4	$1.28M	Sell	153,077 -74,087	-33%	-$632K	﹤0.01%	2597
2024 Q3	$1.58M	Buy	227,164 +97,434	+75%	+$661K	﹤0.01%	2539
2024 Q2	$636K	Hold	129,730	–	–	﹤0.01%	2914
2024 Q1	$752K	Hold	129,730	–	–	﹤0.01%	2816
2023 Q4	$850K	Hold	129,730	–	–	﹤0.01%	2805
2023 Q3	$625K	Hold	129,730	–	–	﹤0.01%	2766
2023 Q2	$662K	Buy	+129,730	New	+$699K	﹤0.01%	2839
2022 Q2	–	Sell	-101,793	Closed	-$516K	–	3512
2022 Q1	$516K	Buy	101,793 +1,566	+2%	+$9.96K	﹤0.01%	3008
2021 Q4	$748K	Sell	100,227 -6,813	-6%	-$60.8K	﹤0.01%	2953
2021 Q3	$972K	Sell	107,040 -3,677	-3%	-$37.1K	﹤0.01%	2994
2021 Q2	$1.42M	Buy	+110,717	New	+$1.19M	﹤0.01%	2865

Other funds holding ZVRA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legal & General Group

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return